Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    May 2021
  1. LEE CL, Brock KD, Hasapis S, Zhang D, et al
    Whole exome sequencing of radiation-induced thymic lymphoma in mouse models identifies Notch1 activation as a driver of p53 wild-type lymphoma.
    Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-2823.
    PubMed     Abstract available


    December 2020
  2. FARRIA AT, Plummer JB, Salinger AP, Shen J, et al
    Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.
    Cancer Res. 2020;80:5543-5553.
    PubMed     Abstract available


    November 2020
  3. ARUMOV A, Liyanage PY, Trabolsi A, Roberts ER, et al
    Optimized doxorubicin chemotherapy for diffuse Large B-Cell lymphoma exploits nanocarrier delivery to transferrin receptors.
    Cancer Res. 2020 Nov 11. pii: 0008-5472.CAN-20-2674.
    PubMed     Abstract available


    October 2020
  4. TATEISHI K, Miyake Y, Kawazu M, Sasaki N, et al
    A hyperactive RelA/p65-hexokinase 2 signaling axis drives primary central nervous system lymphoma.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-2425.
    PubMed     Abstract available


    September 2020
  5. SUGIHARA E, Hashimoto N, Osuka S, Shimizu T, et al
    The inhibitor of apoptosis protein Livin confers resistance to Fas-mediated immune cytotoxicity in refractory lymphoma.
    Cancer Res. 2020 Sep 14. pii: 0008-5472.CAN-19-3993.
    PubMed     Abstract available


    April 2020
  6. SAFFIE R, Zhou N, Rolland D, Onder O, et al
    FBXW7 triggers degradation of KMT2D to favor growth of diffuse large B-cell lymphoma cells.
    Cancer Res. 2020 Apr 29. pii: 0008-5472.CAN-19-2247.
    PubMed     Abstract available


    February 2020
  7. NGUYEN TB, Sakata-Yanagimoto M, Fujisawa M, Tanzima Nuhat S, et al
    Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma.
    Cancer Res. 2020 Feb 27. pii: 0008-5472.CAN-19-2787.
    PubMed     Abstract available


    January 2020
  8. GLOGER M, Menzel L, Grau M, Vion AC, et al
    Lymphoma angiogenesis is orchestrated by noncanonical signaling pathways.
    Cancer Res. 2020 Jan 13. pii: 0008-5472.CAN-19-1493.
    PubMed     Abstract available


  9. KLINGER M, Zugmaier G, Nagele V, Goebeler ME, et al
    Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events.
    Cancer Res. 2020;80:91-101.
    PubMed     Abstract available


    July 2019
  10. ROSS J, Rashkovan M, Fraszczak J, Joly Beauparlant C, et al
    Deletion of the Miz-1 POZ domain increases efficacy of cytarabine treatment in T- and B-ALL/lymphoma mouse models.
    Cancer Res. 2019 Jul 4. pii: 0008-5472.CAN-18-3038.
    PubMed     Abstract available


    June 2019
  11. GAMBI G, Di Simone E, Basso V, Ricci L, et al
    The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3.
    Cancer Res. 2019;79:3076-3087.
    PubMed     Abstract available


    May 2019
  12. POLONEN P, Mehtonen J, Lin J, Liuksiala T, et al
    Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies.
    Cancer Res. 2019;79:2466-2479.
    PubMed     Abstract available


    April 2019
  13. HULLEIN J, Slabicki M, Rosolowski M, Jethwa A, et al
    MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma.
    Cancer Res. 2019 Apr 18. pii: 0008-5472.CAN-18-3438.
    PubMed     Abstract available


    January 2019
  14. HU T, Chong Y, Lu S, Qin H, et al
    Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.
    Cancer Res. 2019;79:114-124.
    PubMed     Abstract available


    May 2018
  15. VERMI W, Micheletti A, Finotti G, Tecchio C, et al
    slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-2344.
    PubMed     Abstract available


  16. WANG SS, Carrington M, Berndt SI, Slager SL, et al
    HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-2900.
    PubMed     Abstract available


  17. HU T, Chong Y, Lu S, Wang R, et al
    MicroRNA 339 promotes development of Stem Cell Leukemia/Lymphoma syndrome via downregulation of the BCL2L11 and BAX pro-apoptotic genes.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4049.
    PubMed     Abstract available


    February 2018
  18. TAYLOR A, Rothstein D, Rudd CE
    Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.
    Cancer Res. 2018;78:706-717.
    PubMed     Abstract available


    January 2018
  19. LU Y, Hu Z, Mangala LS, Stine ZE, et al
    MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.
    Cancer Res. 2018;78:64-74.
    PubMed     Abstract available


    November 2017
  20. BELOUECHE-BABARI M, Wantuch S, Casals Galobart T, Koniordou M, et al
    MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.
    Cancer Res. 2017;77:5913-5924.
    PubMed     Abstract available


  21. ULVE R, Rault M, Bahin M, Lagoutte L, et al
    Discovery of Human-Similar Gene Fusions in Canine Cancers.
    Cancer Res. 2017;77:5721-5727.
    PubMed     Abstract available


    October 2017
  22. SPEHALSKI E, Capper KM, Smith CJ, Morgan MJ, et al
    MRE11 Promotes Tumorigenesis by Facilitating Resistance to Oncogene-Induced Replication Stress.
    Cancer Res. 2017;77:5327-5338.
    PubMed     Abstract available


  23. TANG YC, Yuwen H, Wang K, Bruno PM, et al
    Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.
    Cancer Res. 2017;77:5272-5286.
    PubMed     Abstract available


    September 2017
  24. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    PubMed     Abstract available


  25. HERRMANN A, Lahtz C, Nagao T, Song JY, et al
    CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
    Cancer Res. 2017;77:5118-5128.
    PubMed     Abstract available


    July 2017
  26. FEELEY KP, Adams CM, Mitra R, Eischen CM, et al
    Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells.
    Cancer Res. 2017;77:3823-3833.
    PubMed     Abstract available


  27. O'STEEN S, Green DJ, Gopal AK, Orozco JJ, et al
    Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.
    Cancer Res. 2017;77:3885-3893.
    PubMed     Abstract available


    May 2017
  28. DAHAL LN, Dou L, Hussain K, Liu R, et al
    STING activation reverses lymphoma-mediated resistance to antibody immunotherapy.
    Cancer Res. 2017 May 16. pii: canres.2784.2016.
    PubMed     Abstract available


  29. GREEN DJ, Press OW
    Whither Radioimmunotherapy: To Be or Not To Be?
    Cancer Res. 2017;77:2191-2196.
    PubMed     Abstract available


  30. DEUTSCH AJA, Rinner B, Pichler M, Prochazka K, et al
    NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
    Cancer Res. 2017;77:2375-2386.
    PubMed     Abstract available


    March 2017
  31. MANFROI B, McKee T, Mayol JF, Tabruyn S, et al
    CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.
    Cancer Res. 2017;77:1097-1107.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: